In another study in which targeted cancer exome sequencing was performed in BCR-ABL-negative MPNs, NRAS mutations were found in only 4.7% of 168 patients with primary myelofibrosis (MF) and in none of the patients with polycythemia vera (PV) [41]. The gene discussed is NRAS; the disease is cancer.